Rossari Biotech Limited
NSE:ROSSARI.NS
817.8 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 18,305.58 | 16,558.81 | 14,751.76 | 7,074.08 | 5,981.74 | 5,131.33 | 2,914.38 | 2,348.88 |
| Cost of Revenue
| 14,570.46 | 11,713.12 | 11,107.85 | 4,786.54 | 3,810.75 | 3,475.76 | 2,015.17 | 1,963.18 |
| Gross Profit
| 3,735.12 | 4,845.69 | 3,643.91 | 2,287.54 | 2,170.99 | 1,655.57 | 899.21 | 385.7 |
| Gross Profit Ratio
| 0.204 | 0.293 | 0.247 | 0.323 | 0.363 | 0.323 | 0.309 | 0.164 |
| Reseach & Development Expenses
| 70.17 | 82.55 | 59.53 | 75.01 | 53.53 | 38.62 | 31.39 | 47.1 |
| General & Administrative Expenses
| 169.73 | 153.35 | 151.16 | 84.24 | 57.1 | 35.15 | 32.37 | 0 |
| Selling & Marketing Expenses
| 643.56 | 666.69 | 511.21 | 308.71 | 407.93 | 342.2 | 93.94 | 0 |
| SG&A
| 1,841.46 | 1,021.29 | 662.37 | 392.95 | 465.03 | 377.35 | 126.31 | 141.22 |
| Other Expenses
| 74.46 | 54.84 | 58.17 | 17 | 0.7 | 0.59 | 0.64 | 0 |
| Operating Expenses
| 1,841.46 | 3,244.76 | 2,342.19 | 1,285.17 | 1,290.16 | 999.2 | 523.53 | 188.32 |
| Operating Income
| 1,893.66 | 1,516.32 | 1,292.32 | 1,002.37 | 879.63 | 656.37 | 375.68 | 197.38 |
| Operating Income Ratio
| 0.103 | 0.092 | 0.088 | 0.142 | 0.147 | 0.128 | 0.129 | 0.084 |
| Total Other Income Expenses Net
| -119.26 | -74.13 | 70.43 | 66.01 | -1.22 | -22.45 | -0.94 | -10.27 |
| Income Before Tax
| 1,774.4 | 1,442.19 | 1,362.75 | 1,068.38 | 878.41 | 633.92 | 374.74 | 187.11 |
| Income Before Tax Ratio
| 0.097 | 0.087 | 0.092 | 0.151 | 0.147 | 0.124 | 0.129 | 0.08 |
| Income Tax Expense
| 469.26 | 369.62 | 385.8 | 267.92 | 225.88 | 177.09 | 120.71 | 44.26 |
| Net Income
| 1,306.89 | 1,072.57 | 976.74 | 802.2 | 652.53 | 456.83 | 254.03 | 142.85 |
| Net Income Ratio
| 0.071 | 0.065 | 0.066 | 0.113 | 0.109 | 0.089 | 0.087 | 0.061 |
| EPS
| 23.67 | 19.46 | 17.81 | 15.58 | 13.42 | 9.44 | 5.25 | 6.49 |
| EPS Diluted
| 23.62 | 19.38 | 17.7 | 15.49 | 13.23 | 9.44 | 5.25 | 6.49 |
| EBITDA
| 2,497.56 | 2,294.65 | 1,958.7 | 1,299.33 | 1,084.41 | 788.05 | 440.5 | 240.83 |
| EBITDA Ratio
| 0.136 | 0.139 | 0.133 | 0.184 | 0.181 | 0.154 | 0.151 | 0.103 |